Main Article Content

Abstract

ABSTRACT
Introduction. Hepatitis B is a major public health problem in Cameroon, where over 1.6 million people live with chronic infection and mother-to-child transmission remains a critical issue. Knowledge of the disease among pregnant women is a key determinant of preventing this transmission. This study aimed to assess the level of knowledge about hepatitis B among pregnant women in the Bangourain Health District and to identify associated factors. Methods. We conducted a cross-sectional analytical study from April 1 to June 30, 2025, in all 20 health facilities of the district. A pretested questionnaire was administered to consenting pregnant women. Knowledge level was classified as poor (<60%), moderate (60-79%), and high (≥80%). Multinomial logistic regressions identified associated factors, with significance set at p<0.05. Results. Among 236 participants, mean age was 27.8 years. Only 18.2% (n=43) had a high knowledge level. Most knew about sexual transmission (76.7%), mother-to-child transmission (76.7%), and the risk of liver cancer (76.7%). However, 81.8% were unaware that hepatitis B is not transmitted through air or intact skin contact. In multivariate analysis, residence in the Kouhouat health area (OR=1.46; p=0.040) and a history of blood transfusion (OR=4.63; p=0.044) were associated with higher knowledge. Conclusion. Knowledge about hepatitis B among pregnant women in Bangourain Health District was insufficient. Targeted awareness campaigns, integrating health areas and transfusion history, are needed to improve prevention of mother-to-child transmission.


RÉSUMÉ
Introduction. L'hépatite B constitue un problème de santé publique majeur au Cameroun, où plus de 1,6 million de personnes vivent avec l'infection chronique et où la transmission mère-enfant reste un enjeu crucial. La connaissance de la maladie par les femmes enceintes est un déterminant essentiel de la prévention de cette transmission. Cette étude visait à évaluer le niveau de connaissances sur l'hépatite B chez les femmes enceintes du district de santé de Bangourain et à identifier les facteurs associés. Méthodes. Nous avons mené une étude transversale analytique du 1er avril au 30 juin 2025 dans les 20 structures de santé du district. Un questionnaire pré-testé a été administré aux femmes enceintes consentantes. Le niveau de connaissances a été classé en faible (<60%), moyen (60-79%) et élevé (≥80%). Des régressions logistiques multinomiales ont identifié les facteurs associés, avec un seuil de significativité à p<0,05. Résultats. Sur 236 participantes, l'âge moyen était de 27,8 ans. Seules 18,2% (n=43) présentaient un niveau de connaissances élevé. La majorité connaissait les modes de transmission par voie sexuelle (76,7%), la transmission mère-enfant (76,7%) et le risque de cancer du foie (76,7%). Cependant, 81,8% ignoraient que l'hépatite B ne se transmet pas par l'air ou par contact cutané intact. En analyse multivariée, résider dans l'aire de santé de Kouhouat (OR=1,46; p=0,040) et avoir un antécédent de transfusion sanguine (OR=4,63; p=0,044) étaient associés à un meilleur niveau de connaissances. Conclusion. Les connaissances sur l'hépatite B chez les femmes enceintes du district de Bangourain étaient insuffisantes. Des campagnes de sensibilisation ciblées, intégrant les aires de santé et les antécédents de transfusion, sont nécessaires pour améliorer la prévention de la transmission mère-enfant.

Keywords

Level of knowledge Hepatitis B Pregnant women Bangourain District Niveau de connaissances Hépatite B Femmes enceintes District de Bangourain

Article Details

How to Cite
Kum Jerry Ngha, Margaret Akpan, Phillip Bassey, Kenmegne Noumsi Elvira Christelle, Gilbert Mua Akwa, Ekpo Ofem, … Bernadine Ekpenyong. (2026). Knowlegde on Hepatitis B and Associated Factors amongst Pregnant Women in Bangourain Health District, West Region of Cameroon: Connaissances sur l’Hépatite B et les Facteurs Associés chez les Femmes Enceintes du District Sanitaire de Bangourain, dans la Région Ouest du Cameroun. HEALTH SCIENCES AND DISEASE, 27(9), 60–69. https://doi.org/10.67260/hsd.v27i9.7874

References

  1. • Adeyemi, A. B., Enabor, O. O., Ugwu, I. A., Bello, F. A., & Olayemi, O. O. (2013). Knowledge of hepatitis B virus infection, access to screening and vaccination among pregnant women in Ibadan, Nigeria. Journal of Obstetrics and Gynaecology. (world). https://www.tandfonline.com/doi/abs/10.3109/01443615.2012.711389
  2. • Carey, W. D. (2009). The prevalence and natural history of hepatitis B in the 21st century. Cleveland Clinic Journal of Medicine, 76(5 suppl 3), S2–S5. https://doi.org/10.3949/ccjm.76.s3.01
  3. • Chen, C.-J., & Yang, H.-I. (2011). Natural history of chronic hepatitis B REVEALed. Journal of Gastroenterology and Hepatology, 26(4), 628–638. https://doi.org/10.1111/j.1440-1746.2011.06695.x
  4. • Conners, E. E. (2023). Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. MMWR. Recommendations and Reports, 72. https://doi.org/10.15585/mmwr.rr7201a1
  5. • Eyong, E. M., Yankam, B. M., Seraphine, E., Ngwa, C. H., Nkfusai, N. C., Anye, C. S., Nfor, G. K., & Cumber, S. N. (2019). The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka health districts of the South West region of Cameroon: A three-year retrospective study. The Pan African Medical Journal, 32(122), Article 122. https://doi.org/10.11604/pamj.2019.32.122.16055
  6. • Frambo, A. A. B., Atashili, J., Fon, P. N., & Ndumbe, P. M. (2014). Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: A cross-sectional study. BMC Research Notes, 7(1), 394. https://doi.org/10.1186/1756-0500-7-394
  7. • Gebrecherkos, T., Girmay, G., Lemma, M., & Negash, M. (2020). Knowledge, Attitude, and Practice towards Hepatitis B Virus among Pregnant Women Attending Antenatal Care at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. International Journal of Hepatology, 2020(1), 5617603. https://doi.org/10.1155/2020/5617603
  8. • Global hepatitis report 2024: Action for access in low- and middle-income countries. (n.d.). Retrieved 11 November 2024, from https://www.who.int/publications/i/item/9789240091672
  9. • Han, Z., Yin, Y., Zhang, Y., Ehrhardt, S., Thio, C. L., Nelson, K. E., Bai, X., & Hou, H. (2017). Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China. PLOS ONE, 12(6), e0178671. https://doi.org/10.1371/journal.pone.0178671
  10. • Hou, J., Liu, Z., & Gu, F. (2005). Epidemiology and Prevention of Hepatitis B Virus Infection. International Journal of Medical Sciences, 2(1), 50–57. https://doi.org/10.7150/ijms.2.50
  11. • Kwadzokpui, P. K., Akorsu, E. E., Abaka-Yawson, A., Quarshie, S. S., Amankwah, S. A., & Tawiah, P. A. (2020). Prevalence and Knowledge of Hepatitis B Virus Infection among Pregnant Women in the Ningo-Prampram District, Ghana. International Journal of Hepatology, 2020(1), 7965146. https://doi.org/10.1155/2020/7965146
  12. • Lee, W. M. (1997). Hepatitis B Virus Infection. New England Journal of Medicine, 337(24), 1733–1745. https://doi.org/10.1056/NEJM199712113372406
  13. • Liaw, Y.-F., & Chu, C.-M. (2009). Hepatitis B virus infection. The Lancet, 373(9663), 582–592. https://doi.org/10.1016/S0140-6736(09)60207-5
  14. • Locarnini, S. (2004). Molecular Virology of Hepatitis B Virus. Seminars in Liver Disease, 24(S 1), 3–10. https://doi.org/10.1055/s-2004-828672
  15. • McMahon, B. J. (2005). Epidemiology and Natural History of Hepatitis B. Seminars in Liver Disease, 25(S 1), 3–8. https://doi.org/10.1055/s-2005-915644
  16. • Poddar, U., Benjamin, M., Aggarwal, R., Sarangi, A. N., Mathias, A., Yachha, S. K., & Srivastava, A. (2021). Hepatitis B Transmission: Is Vertical Transmission the Major Route in Intermediate Endemic Areas? A Proof-of-Concept Study Based on Mother–Child Genotypes. The American Journal of Tropical Medicine and Hygiene, 105(6), 1569–1574. https://doi.org/10.4269/ajtmh.21-0283
  17. • Samje, M., Sop, S., Tayou, C. T., & Mbanya, D. (2021). Knowledge, attitude and seropositivity of hepatitis B virus among blood donors in the Bamenda Regional Hospital Blood Bank, Cameroon. The Pan African Medical Journal, 39, 33. https://doi.org/10.11604/pamj.2021.39.33.28911
  18. • Seeger, C., & Mason, W. S. (2000). Hepatitis B Virus Biology. Microbiology and Molecular Biology Reviews, 64(1), 51–68. https://doi.org/10.1128/mmbr.64.1.51-68.2000
  19. • Van Damme, P., Hendrickx, G., Jindal, S., Valckx, S., Vorsters, A., Bino, S., Bonanni, P., Buti, M., Chevaliez, S., Dudareva, S., Domínguez, A., Dragojević, I., Hutchinson, S., Jilg, W., Kane, M., Kojouharova, M., Lavanchy, D., FitzSimons, D., Mandal, S., … Ward, J. W. (2025). The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth. Human Vaccines & Immunotherapeutics, 21(1), 2600657. https://doi.org/10.1080/21645515.2025.2600657
  20. • Wilkins, T., Sams, R., & Carpenter, M. (2019). Hepatitis B: Screening, Prevention, Diagnosis, and Treatment. American Family Physician, 99(5), 314–323.
  21. • Zanetti, A. R., Van Damme, P., & Shouval, D. (2008). The global impact of vaccination against hepatitis B: A historical overview. Vaccine, Selected Papers from the 1st Global Vaccine Conference, 26(49), 6266–6273. https://doi.org/10.1016/j.vaccine.2008.09.056

Most read articles by the same author(s)